Mitochondrial Oxidative Stress and Vascular Health in Chronic Kidney Disease
Recruiting in Palo Alto (17 mi)
DG
DL
Overseen byDanielle L Kirkman, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 4
Waitlist Available
Sponsor: University of Delaware
Prior Safety Data
Trial Summary
What is the purpose of this trial?
The purpose of this study is to examine the effect of mitochondria derived oxidative stress on vascular function in patients with moderate to severe Chronic Kidney Disease.
Research Team
DG
David G Edwards, PhD
Principal Investigator
University of Delaware
DL
Danielle L Kirkman, PhD
Principal Investigator
University of Delaware
Eligibility Criteria
Inclusion Criteria
Stage 3 - 5 Chronic Kidney Disease
Treatment Details
Interventions
- MitoQ (Antioxidant)
- Placebo (Dietary Supplement)
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: MitoQExperimental Treatment1 Intervention
4 week 20mg oral daily dose of MitoQ
Group II: PlaceboPlacebo Group1 Intervention
4 week 20mg oral daily placebo
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Department of Kinesiology and Applied Physiology, University of DelawareNewark, DE
Loading ...
Who Is Running the Clinical Trial?
University of Delaware
Lead Sponsor
Trials
167
Patients Recruited
25,700+